Product
Grafalon
3 clinical trials
3 indications
Indication
Graft-versus-host diseaseIndication
Leukemia, Acute LymphoblasticIndication
Kidney Transplant Failure and RejectionClinical trial
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaemiaStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor Following a Reduced Intensity Conditioning Regimen by Fludarabine-treosulfanStatus: Not yet recruiting, Estimated PCD: 2027-02-15
Clinical trial
Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients: a Spanish Multicenter, Randomized, Controlled Parallel-group Trial: The TRAINING StudyStatus: Recruiting, Estimated PCD: 2024-06-01